OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis

Vaccine

Volumn 32, Issue 45, 2014, Pages 5918-5924

  Yanase, Noriko ^a   Toyota, Hiroko ^a   Hata, Kikumi ^a   Yagyu, Seina ^a   Seki, Takahiro ^a   Harada, Mitsunori ^b   Kato, Yasuki ^b   Mizuguchi, Junichiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NanoCarrier Co Ltd   (Japan)

Author keywords

Adjuvants; Antibody responses; Formulation; Nanoparticles; Vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; INTERLEUKIN 21; INTERLEUKIN 4; NANOPARTICLE; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ALUMINUM POTASSIUM SULFATE; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; OVALBUMIN-ALUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; SPLEEN; T LYMPHOCYTE; TH2 CELL; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; BIOSYNTHESIS; IMMUNOLOGY; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CYTOKINES; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICE, INBRED BALB C; NANOPARTICLES; OVALBUMIN; TH1 CELLS; TH2 CELLS;

EID: 84907992906     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.059     Document Type: Article

References (34)

1. Schijns V.E. Induction and direction of immune responses by vaccine adjuvants. Crit Rev Immunol 2001, 21(1-3):75-85.
2. Bomford R. Adjuvants for anti-parasite vaccines. Parasitol Today 1989, 5(2):41-46.
3. Lindblad E.B. Aluminium adjuvants - in retrospect and prospect. Vaccine 2004, 22(27-28):3658-3668.
4. Gupta R.K., Relyveld E.H., Lindblad E.B., Bizzini B., Ben-Efraim S., Gupta C.K. Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 1993, 11(3):293-306.
5. Geha R.S., Jabara H.H., Brodeur S.R. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003, 3(9):721-732.
6. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298(5598):1630-1634.
7. Finkelman F.D., Holmes J., Katona I.M., Urban J.F., Beckmann M.P., Park L.S., et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990, 8:303-333.
8. Snapper C.M., Mond J.J. Towards a comprehensive view of immunoglobulin class switching. Immunol Today 1993, 14(1):15-17.
9. Snapper C.M., Paul W.E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987, 236(4804):944-947.
10. McIntyre T.M., Klinman D.R., Rothman P., Lugo M., Dasch J.R., Mond J.J., et al. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med 1993, 177(4):1031-1037.
11. Indik Z.K., Park J.G., Hunter S., Mantaring M., Schreiber A.D. Molecular dissection of Fc gamma receptor-mediated phagocytosis. Immunol Lett 1995, 44(2-3):133-138.
12. Sulica A., Morel P., Metes D., Herberman R.B. Ig-binding receptors on human NK cells as effector and regulatory surface molecules. Int Rev Immunol 2001, 20(3-4):371-414.
13. Turner M.L., Corcoran L.M., Brink R., Hodgkin P.D. High-affinity B cell receptor ligation by cognate antigen induces cytokine-independent isotype switching. J Immunol 2010, 184(12):6592-6599.
14. Taneichi M., Naito S., Kato H., Tanaka Y., Mori M., Nakano Y., et al. T cell-independent regulation of IgE antibody production induced by surface-linked liposomal antigen. J Immunol 2002, 169(8):4246-4252.
15. Oshiba A., Gelfand E.W. Engagement of the B-cell antigen receptor by antigen negatively regulates IgE production by antigen-specific B cells. J Allergy Clin Immunol 1999, 103(2 Pt 1):341-348.
16. Mond J.J., Stein K.E., Subbarao B., Paul W.E. Analysis of B cell activation requirements with TNP-conjugated polyacrylamide beads. J Immunol 1979, 123(1):239-245.
17. Hinton H.J., Jegerlehner A., Bachmann M.F. Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors. Curr Top Microbiol Immunol 2008, 319:1-15.
18. Peek L.J., Middaugh C.R., Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 2008, 60(8):915-928.
19. Rice-Ficht A.C., Arenas-Gamboa A.M., Kahl-McDonagh M.M., Ficht T.A. Polymeric particles in vaccine delivery. Curr Opin Microbiol 2010, 13(1):106-112.
20. Matsumura Y., Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci 2009, 100(4):572-579.
21. Cohen S.A., De Antonis K.M. Applications of amino acid derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate. Analysis of feed grains, intravenous solutions and glycoproteins. J Chromatogr A 1994, 661(1-2):25-34.
22. Cao Y., Takada E., Hata K., Sudo K., Furuhata M., Mizuguchi J. Enhanced T cell-independent antibody responses in c-Jun N-terminal kinase 2 (JNK2)-deficient B cells following stimulation with CpG-1826 and anti-IgM. Immunol Lett 2010, 132(1-2):38-44.
23. Yoo J.W., Irvine D.J., Discher D.E., Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov 2011, 10(7):521-535.
24. Xiang S.D., Scholzen A., Minigo G., David C., Apostolopoulos V., Mottram P.L., et al. Pathogen recognition and development of particulate vaccines: does size matter?. Methods 2006, 40(1):1-9.
25. Kanchan V., Panda A.K. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 2007, 28(35):5344-5357.
26. Fifis T., Gamvrellis A., Crimeen-Irwin B., Pietersz G.A., Li J., Mottram P.L., et al. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol 2004, 173(5):3148-3154.
27. Gutierro I., Hernandez R.M., Igartua M., Gascon A.R., Pedraz J.L. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 2002, 21(1-2):67-77.
28. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003, 171(10):4969-4973.
29. Pinna D., Corti D., Jarrossay D., Sallusto F., Lanzavecchia A. Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol 2009, 39(5):1260-1270.
30. Rankin A.L., MacLeod H., Keegan S., Andreyeva T., Lowe L., Bloom L., et al. IL-21 receptor is critical for the development of memory B cell responses. J Immunol 2011, 186(2):667-674.
31. Paus D., Phan T.G., Chan T.D., Gardam S., Basten A., Brink R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med 2006, 203(4):1081-1091.
32. Hata K., Yoshimoto T., Mizuguchi J. CD40 ligand rescues inhibitor of differentiation 3-mediated G1 arrest induced by anti-IgM in WEHI-231 B lymphoma cells. J Immunol 2004, 173(4):2453-2461.
33. Sugai M., Gonda H., Kusunoki T., Katakai T., Yokota Y., Shimizu A. Essential role of Id2 in negative regulation of IgE class switching. Nat Immunol 2003, 4(1):25-30.
34. Osada K., Christie R.J., Kataoka K. Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J R Soc Interface 2009, 6(Suppl. 3):S325-S339.